Tumor type | Interactions | Cell line | Function | References |
---|---|---|---|---|
Acute myeloid leukemia | miR-874-3P/ATG16L1 axis | HL60, U937, and KG1a | DANCR is involved in Ara‐C resistance and promotes autophagy in HL60 cells via regulating ATG16L1 | [33] |
Bladder cancer | miR-335/VEGF-C axis | SW780, 5637, T24, UM-UC-3, SV-HUC-1, and T24 | ∆ DANCR: ↓proliferation, migration, invasion and lymphatic metastases | [7] |
IL-11-STAT3 signaling and CCND1 | UM-UC-3, T24 and 293T | DANCR was found to promote bladder cancer progression | [8] | |
miR-149/MSI2 axis | 5637, SW780, UM-UC-3, T24 and SV-HUC-1 | ∆ DANCR: ↓ proliferation, migration, invasion and EMT process | [9] | |
Breast cancer | PI3K/AKT signaling | BT549, MCF7, T47D, MDA-MB-231, MDA-MB-453, and MDA-MB-468 and MCF10A | ∆ DANCR: ↓ proliferation and tumor growth DANCR is involved in enhancing PI3K/AKT signaling by binding with RXRA and increasing its serine 49/78 phosphorylation | [27] |
miR-4319/VAPB axis | MCF-10A, MCF-7 and HCC38 | ∆ DANCR: ↓ proliferation, migration, invasion, and ↑ apoptosis | [28] | |
EZH2, SOCS3 | MCF10A, MCF7, T47D, MDA‐MB‐231, and MDA‐MB‐468 | ∆ DANCR: ↓ viability, migration and invasion DANCR epigenetically inhibits SOCS3 expression | [29] | |
miR-758-3p-PAX6 axis | HCC1937, 1590, ZR-75-30, MDA-MB-468 and MCF-10A | ∆ DANCR: ↓ proliferation and ↑ apoptosis | [34] | |
miR-216a-5p | MCF-7, MDA-MB-231 and MCF-10A | ∆ DANCR: ↓ proliferation, migration, and invasion | [35] | |
miR-874-3p/SOX2 axis | MCF10A, ZR751, MCF7, SKBR3, BT474, MDA-MB-231, MDA-MB-468 cells | ∆ DANCR: ↓ proliferation TUFT1 induces the expression of DANCR | [36] | |
EZH2, CD44 and ABCG2 | Hs578Bst, MCF-7, T47D, MDA-MB-468 and MDA-MB-231 | ∆ DANCR: ↓ proliferation and invasion and ↑ binding of EZH2 on the promoters of CD44 and ABCG2, so reduction of expression of these genes | [37] | |
PRC2, Wnt/EMT signaling | HMECs, MCF7, ZR-75–1, MDA-MB-231, Hs578T, and BT549 | RGD-PEG-ECO/siDANCR nanoparticles: ↓ proliferation, invasion and migration | [38] | |
Cervical cancer | miR-335-5p/ROCK1 axis | aski, SW756, SiHa, C33A, HeLa, ME‐180, and End1/E6E7 | ∆ DANCR: ↓ proliferation, migration, and invasion | [39] |
FRAT1, FRAT2 and Wnt/β-catenin signaling pathway | HCerEpiC, HeLa, SiHa, C-33A, and ME-180 | ∆ DANCR: ↓ proliferation FRAT1 and FRAT2 are up-regulated by DANCR and the Wnt/β-catenin signaling pathway is activated by DANCR | [40] | |
miR-145-3p/ZEB1 axis and KLF5 | HeLa, SiHa, and H8 | KLF5-induced up-regulation of DANCR up-regulates ZEB1 via sponging miR-145-3p to promote the progression of cervical cancer | [41] | |
miR-665/TGFBR1 axis and ERK/SMAD pathway | Endl/E6E7 and H8 | ↑↑ miR-665 (a target of DANCR): ↓ proliferation, migration, and invasion miR-665 reduces TGFBR1 levels and inactivates ERK/SMAD pathway | [42] | |
miR-345-5p/Twist1 axis | HuH28, HuCCT1, SG231, and H69 | ∆ DANCR: ↓ proliferation, migration, invasion, EMT and angiogenesis and ↑ apoptosis | [43] | |
Cholangiocarcinoma | EZH2 and FBP1 | HuCCT1 and RBE | ∆ DANCR: ↓ proliferation, migration DANCR could modulate the histone methylation of promoter of FBP1by binding with EZH2 | [44] |
miR-125b-5p/HK2 axis | HT-29, SW620, HCT116, SW480, DLD-1, and CRL-1790 | ∆ DANCR: ↓ glycolysis rate and ↑ cisplatin sensitivity | [21] | |
Colorectal cancer | miR-518a-3p/MDM2 axis, Smad2/3 and p53 | HT29, HCT116, SW116, Caco-2, and FHC | ∆ DANCR: ↓ proliferation, viability, metastasis | [22] |
– | SW620, SW480, HCT116, HT29, HCT15, Caco-2, and HCoEpiC | ∆ DANCR: ↓ proliferation, colony formation, and ↑ apoptosis | [45] | |
MALAT1 and QK | HCT116, RKO, SW620, HT-29, and LoVo | DANCR inhibits Doxorubicin-induced apoptosis via enhancing the RNA stability of MALAT1 and interacting with QK | [23] | |
miR-185-5p/HMGA2 axis | NCM460 and the CRC cell lines LoVo, SW620, SW480, and HT29 | ∆ DANCR: ↓ proliferation, migration, invasion and cell cycle progression, and ↑ apoptosis | [46] | |
KAT6A | LOVO, SW480, HCT116, SW620, and HT29 | ∆ DANCR: ↓ proliferation, cell cycle progression, and tumorigenesis DANCR was found to bind with lysine acetyltransferase 6A to mediate KAT6A acetyltransferase activity | [47] | |
miR-145-5p/NRAS axis | – | DANCR showed an indirect effect on NRAS expression levels via targeting miR-145-5p | [48] | |
miR-577/HSP27 axis | HT29, HCT116, SW480, and LOVO and NCM460 | ∆ DANCR: ↓ proliferation and metastasis | [49] | |
miR-214 | KLE, RL95-2, ishikawa, AN3CA, and HEC-1B | ∆ DANCR: ↓ proliferation and ↑ apoptosis | [50] | |
Endometrial carcinoma | ZNF750, and miR-4707-3p/FOXC2 axis | SHEE, KYSE140, KYSE150, KYSE180, KYSE410, KYSE510, KYSE450, Colo680N, and ECA109 | Down-regulation of ZNF750 induces DANCR expression, thus inhibits miR-4707-3p to interact with FOXC2, resulting in enhanced FOXC2 signaling and angiogenesis | [51] |
Esophageal squamous cell carcinoma | miR-33a-5p/ZEB1 axis | EC9706, EC109, EC1, KYSE150, and Het-1A | ↑↑ miR-33a-5p (a target of DANCR): ↓ proliferation and metastasis | [52] |
– | ECA109 and TE-1 | ∆ DANCR: ↓ proliferation, migration, invasion, and ↑ apoptosis | [53] | |
Gastric cancer | MDR1 and MRP1 | SGC7901 and BGC823 | ∆ DANCR: ↓ survival and increased apoptosis | [30] |
miR-194/AKT2 axis and | SGC7901, MGC-803, NCI-N87, and GES-1 | ∆ DANCR: ↓ viability, ↑ autophagy, and apoptosis KLF5 is involved in activating the transcription of DANCR | [31] | |
SALL4 and β-catenin pathway | GES-1, BGC-823, MGC-803, HGC-27 and MKN-45 | ∆ DANCR: ↓ proliferation, migration, invasion and EMT process, ↑ cell cycle arrest and apoptosis DANCR activated by SALL4 plays its oncogenic roles via the activation of β-catenin pathway | [32] | |
– | SGC7901, MGC803, and MKN-45 | ∆ DANCR: ↓ proliferation, and ↑ cell cycle arrest | [54] | |
Glioma | miR-135a-5p/BMI1 axis | LN229, U251 and NHAs | ∆ DANCR: ↓ proliferation, migration and invasion | [55] |
miR-33a-5p | HEB, U87, U251, LN22 9 and T98G | ∆ DANCR: ↓ proliferation, migration, and EMT process, and ↑ apoptosis | [56] | |
Wnt/β-catenin signaling | U87, U251, SGC7901 and BGC823 | ∆ DANCR: ↓ proliferation, migration, and EMT process | [57] | |
miR-33a-5p, miR-33b-5p, miR-1-3p, miR-206, and miR-613/AXL axis and PI3K/Akt/NF-κB signaling pathway | U87MG, U251MG, LN18 and U138MG | ↑↑ DANCR: ↓ sensitivity of glioma cells to cisplatin ∆ DANCR: ↑ sensitivity of glioma cells to cisplatin DANCR up-regulates AXL to actives PI3K/Akt/NF-κB signaling pathway | [58] | |
miR-634/RAB1A axis | U251, U118, LN229, U87MG, and NHA | ∆ DANCR: ↓ proliferation and ↑ G0/G1 phase arrest | [59] | |
miR-216a/LGR5, PI3K/AKT | SHG-44, U87MG, U118MG, and U251MG | ∆ DANCR: ↓ proliferation, migration, invasion, angiogenesis, and ↑ phase arrest and apoptosis | [60] | |
IGF2BP2, FOXO1, PID1 | U251MG, LN229, LN18, T98G, and HEK293T | IGF2BP2 increases DANCR stability and decreases DANCR methylation. DANCR indices ubiquitination of FOXO1 via interacting with FOXO1. PID1 promoted by FOXO1 enhances the chemotherapy sensitivity of GBM cells | [61] | |
miR-125b-5p/MAPK pathway axis | HepG2 and Huh-7 cells | ∆ DANCR: ↓ migration, invasion | [15] | |
Hepatocellular carcinoma | miR-216a-5p/KLF12 axis | Huh7, HepG2 and LO2 cells | ∆ DANCR: ↓ proliferation, migration, invasion and ↑ apoptosis | [16] |
miR-222-3p/ ATG7 axis | Bel7407, Hep3B, HepG2, Huh7, MHCC97H and LO2 | ∆ DANCR: ↓ proliferation and autophagy | [17] | |
PSMD10-IL-6/STAT3 signaling axis | HEK-293T, Huh7 and Hep3B | DANCR promotes sorafenib resistance via PSMD10-IL-6/STAT3 signaling axis | [18] | |
CTNNB1 | HCC cells | DANCR is involved in stemness features of hepatocellular carcinoma by derepression of CTNNB1 | [19] | |
miR-27a-3p/ROCK1/LIMK1/COFILIN1 pathway axis | MHCC‐97H, Huh7, HCC‐LM3, HepG2, MHCC‐97L, Hep3B, SMMC‐7721 and LO2 | ∆ DANCR: ↓ proliferation, and metastasis | [20] | |
β-catenin pathway | SMMC-7721 and HCCLM3 | ∆ DANCR: ↓ proliferation and metastasis | [62] | |
miR-216a | BEAS-2B, NCI-H1299, A549, and NCI-H1975 | ∆ DANCR: ↓ proliferation and colony formation | [10] | |
Lung cancer | miR-1225-3p/ ErbB2 axis | 16HBE, A549, SPCA1, H1299 and H1975 | ∆ DANCR: ↓ Migration and Invasion | [11] |
miR-214-5p/CIZ1 axis | 16HBE, A549, SPCA1, H1299, and H358 | ∆ DANCR: ↓ proliferation and ↑ apoptosis | [13] | |
miR-496/mTOR axis | A549, H1299, H358, (HEK) 293T cells and HBE | ∆ DANCR: ↓ proliferation, migration, invasion and ↑ apoptosis | [12] | |
HMGA2 | 16HBE, SPCA1, A549, H1299 and H1975 | ∆ DANCR: ↓ invasion ↑↑ DANCR: ↑ invasion via increasing HMGA2 | [63] | |
miR-216a and Wnt/β-catenin pathway | A549, H1975, H1755, H1944, H2087, H358, H661 and H1299 | ∆ DANCR: ↓ proliferation, stemness, migration, invasion | [14] | |
p21 | A549, H1299, H358 and BEAS-2B | ∆ DANCR: ↓ proliferation, migration, invasion EMT process, ↑ apoptosis and cell cycle arrest DANCR inhibits p21 expression | [64] | |
miR-138/Sox4 axis | NHBE, HEK-293T, A549, H1299, H460, SK-MES-1, and Calu-3 | ∆ DANCR: ↓ proliferation, migration, invasion EMT process, and ↑ apoptosis | [65] | |
miR-758-3p | SPC-A, NCL-H1650, NCL-H1975, SK-MES-1, A549, NCL-H358, NCI-H1299 and 16HBE | ∆ DANCR: ↓ viability, proliferation and ↑ cell cycle arrest | [66] | |
– | HT-29 and FHC | ∆ DANCR: ↓ proliferation, migration, invasion EMT process, and metastasis | [67] | |
miR-135b-5p/KLF9 axis | MM cells | ∆ DANCR: ↓ proliferation, migration, and invasion | [68] | |
Multiple myeloma | IL-6/JAK1/STAT3 signaling | NP460, CNE1, CNE2, HNE1, HNE2, HONE1, 5–8 F, and 6-10B | ∆ DANCR: ↓ proliferation and invasion IL-6 is involved in DANCR expression upregulation via an STAT3-dependent manner DANCR interacts with STAT3 and enhances JAK1 binding to STAT3 | [69] |
Nasopharyngeal carcinoma | RBM3 and SOX2 | C666-1, SUNE-1, HNE-1, CNE1, CNE2, and NP69 | ∆ DANCR: ↓ proliferation, colony formation DANCR functions as an oncogene via binding to RBM3 to stabilize SOX2 mRNA | [70] |
PTEN, AKT | 5-8F, SUNE-1, C666-1, and NP69 | ∆ DANCR: ↓ proliferation, colony formation, and migration, and ↑ apoptosis DANCR is involved in expression of PTEN | [71] | |
EZH2 and PTEN | SUNE-1 and 5-8F | ∆ DANCR: ↓ cell growth and migration DANCR mediates the binding of EZH2 on PTEN promoter to down-regulate PTEN expression | [72] | |
HIF-1α, NF90/NF45 complex | SUNE-1, HONE-1, CNE-1, CNE-2, HNE-1, 5-8F, 6-10B and C666-1, and S18 and S26 | ∆ DANCR: ↓ migration and invasion DANCR increases stability of HIF-1α mRNAs | [73] | |
miR-338-3p/B4GALT3 axis | neuroblastoma cells | ∆ DANCR: ↓ proliferation and ↑ apoptosis | [74] | |
Neuroblastoma | miR-216a-5p/Bcl-2/KLF12 axis | SCC9, SCC15, SCC25, CAL-27 and Tca8113, and NHOKs | ∆ DANCR: ↓ proliferation, migration, invasion, and ↑ apoptosis | [75] |
Oral squamous cell carcinoma | miR-335-5p/miR-1972/ROCK1 axis | MG-63, U2OS, MNNG/HOS, 143B and hFOB 1.19 | ∆ DANCR: ↓ proliferation, migration, invasion and metastasis | [3] |
Osteosarcoma | miR-33a-5p/AXL axis, PI3K-Akt signaling pathway | MG63, U2OS, SaOS2, HOS, and 143B FOB, and fibroblast NIH3T3 and 293T | ∆ DANCR: ↓ proliferation, migration, invasion | [2] |
miR-149/MSI2 axis | hFOB1.19 and Saos-2 | ∆ DANCR: ↓ proliferation, migration, invasion | [4] | |
miR-216a-5p/SOX5 axis | MG-63, U2OS, 143B and hFOB 1.19 | ∆ DANCR: ↓ proliferation, migration, invasion and autophagy and ↑ apoptosis | [5] | |
METTL3 | Saos-2, SJSA-1, MG63, HOS, and U-2 OS, and hFOB 1.19 | ∆ DANCR: ↓ proliferation, migration, invasion METTL3 was found to regulate DANCR expression by m6A modification-mediated DANCR mRNA stability | [6] | |
SP1 | CAOV3, SKOV3, A2780 | ∆ DANCR: ↓ viability, migration and invasion SP1 could induce DANCR expression by binding to the promoter region of DANCR in ovarian cancer tissues and cells | [76] | |
Ovarian cancer | miR-214/TGF-ß axis | A2780 and SKOV3 | ∆ DANCR: ↓ viability, migration and invasion, and ↑ apoptosis | [77] |
miR-145/VEGF axis | A2780, PA‐1, SKOV3, HO8910, and HOEC | ∆ DANCR: ↓ tube formation, angiogenesis, and invasion | [78] | |
UPF1 | IOSE-386, SKOV-3, OVCAR3, HO8910, and HEY | ↑↑ DANCR: ↑ proliferation, migration via negatively regulating UPF1 level | [79] | |
miR-33b/MMP16 axis | AsPC‐1, PANC‐1, CFPAC‐1, SW1990, BxPC‐3 and HPDE6‐C7 | ∆ DANCR: ↓ proliferation, migration, and invasion and EMT process | [24] | |
Pancreatic cancer | miR-214-5p/E2F2 axis | PANC-1, SW1990, CAPAN-1, BxPC-3, AsPC-1 and HPDE6-C7 | ∆ DANCR: ↓ growth and metastasis | [25] |
miR-33a-5p/AXL axis | Panc1, Panc28, AsPC1, MiaPaCa2 and BxPC3 and HPDE | ∆ DANCR: ↓ proliferation, and colony formation | [80] | |
miR-135a /NLRP3 axis | BxPC-3, MIA-PaCa-2, CFPAC-1, PANC-1, SW1990 and HPDE6-C7 | ∆ DANCR: ↓ proliferation and invasion | [26] | |
miR-135a | RWPE-1, PC3, C4-2 and DU145 | ∆ DANCR: ↑ Paclitaxel Sensitivity | [81] | |
Prostate cancer | miR-185-5p/LASP1 axis and FAK/PI3K/AKT/GSK3β/Snail pathway | C4-2, PC3, DU145, LNCaP, 22RV1, and RWPE-1 | ∆ DANCR: ↓ proliferation, migration, invasion, G1-S transition and EMT process | [82] |
miR-214-5p/TGF-β axis | DU145, 22Rv1, RC-92a, PC-3M and RWPE-1 | ↑↑ DANCR: ↑ proliferation and migration, and ↓ apoptosis | [83] | |
miR-34a-5p/JAG1 axis | DU145 and PC3 | ∆ DANCR: ↑ sensitivity to docetaxel | [84] | |
TIMP2/3, EZH2 | CWR22Rv1, PC-3, and C4-2B | ∆ DANCR: ↓ migration and invasion ↑↑ DANCR: ↑ invasion and metastasis | [85] | |
– | 786-O and ACHN | ↑↑ DANCR: ↓ proliferation, migration and invasion, and ↑ apoptosis | [86] | |
Renal cell carcinoma | miR-34c and miR-613/ MMP-9 axis | Weri-Rb1, Y79, SO-RB50, HXO-RB44, ARPE-19, and hTERT-RPE1 | ∆ DANCR: ↓ proliferation, migration, invasion, and EMT process | [87] |
Retinoblastoma | miR-135a-5p/KLF8 axis and MMP-2/9 | SCC9, TSCCA, TCa-8113, CAL-27 cells, and SCC9 | ∆ DANCR: ↓ proliferation, viability, migration and invasion | [88] |
Tongue squamous cell carcinoma |